Board of Directors
Company Risk
There is a risk that state hospitals may not renew their contracts with the company, which could impact the company's revenue.
In 2025, the company's services complied with the standards of the Nephrology Society and adhered to all terms and conditions of hospital service contracts. Furthermore, the company's hemodialysis operations department consistently recorded and monitored contract expiration dates to prepare for contract renewals with hospitals on a monthly basis. In addition, the company has consistently maintained good relationships with public hospitals and their management teams. As a result, in 2025, the company successfully renewed its contracts with hospitals. The group of companies also expanded its branches to cover most areas of the country, and the number of hemodialysis machines increased annually. As of December 31, 2025, the group of companies had 39 branches of hemodialysis units in hospitals and hemodialysis medical clinics, and provided 548 hemodialysis machines for these units in hospitals and hemodialysis medical clinics.
resulting in a personnel shortage for the company
In 2025, the company did not experience any shortage of such personnel. This is because the company recognizes the importance of medical personnel and has prepared a personnel development plan, including Human Resource Management, to retain talented personnel within the company for an extended period. This involves promoting learning, emphasizing employees learning from real-world experience with guidance from executives or supervisors, fostering a positive work attitude to create organizational commitment, and regularly reviewing compensation and welfare policies to ensure they are appropriate and fair. Furthermore, a Succession Plan has been established to continuously enhance knowledge. This enables the company to mitigate the risk of specialized personnel shortages and ensure continuity in effective human resource management. Additionally, the company's executives maintain good relationships with nursing groups in those areas, which serves as another crucial channel for broad access to such personnel. Therefore, the company believes that the aforementioned approaches will reduce the risk of personnel shortages in these professions. In 2025, the company also signed an MOU with Burapha University to establish a specialized virtual simulation training center for hemodialysis, to support teaching and learning in the specialized nursing program for kidney disease, specifically in the field of renal replacement therapy nursing practice, Faculty of Nursing, Burapha University, to prepare personnel. Additionally, an MOU was signed with Phra Dabos School to send students for internships, in preparation for business growth plans and the expansion of hemodialysis services.
Consequently, the relevant regulatory government agencies may consider suspending or revoking the license, or not renewing the company's license.
In 2025, the Group is able to comply with established standards and consistently obtain or maintain the licenses required for its business operations. There has never been any reason for the revocation of the company's business licenses. Furthermore, the Group has established a dedicated operational department responsible for coordinating with government agencies and external bodies overseeing the Group's operations to apply for certification, renew, or register relevant licenses. This department also closely monitors changes in regulations, rules, and laws pertinent to the company. In addition, the Group provides knowledge enhancement for management and employees on critical issues, including monitoring and auditing all related operational processes, to ensure that the Group conducts its business in strict compliance with all relevant regulations, rules, laws, and requirements.
There may be a risk in managing cash liquidity.
In 2025, the Group has effectively managed its liquidity and has not experienced any liquidity problems in its operations. Should a decrease in cash flow be anticipated in the near future, the Group will implement the following liquidity management plan: 1. Future branch expansion plans will increasingly focus on establishing hemodialysis clinics to ensure faster receipt of service fees in cash. 2. Responsible staff teams are assigned to follow up with customers at every stage, including monthly debt collection, to expedite the payment of outstanding service fees. 3. Finance personnel prepare financial forecasts and report directly to management every 15 days. These forecasts are prepared to assess the group's total cash flow, which enables management and relevant departments to plan proactively before encountering liquidity issues. 4. The Group plans for sufficient reserve funding sources, including short-term credit lines from banks, such as overdraft facilities. Furthermore, the Group maintains good relationships with several banks, allowing the company to negotiate for additional loans if further funding is required.
Should the company fail to adhere to the stipulated contractual obligations, it may constitute a breach of contract, potentially leading to contract termination or the imposition of penalties.
In 2025, the company's orders for ducting equipment met the conditions specified in the contract, leading to continuous contract renewals since 2015. Furthermore, the company has established a sales and marketing department responsible for coordination and for overseeing that the company consistently adheres to the conditions stipulated in the contract.
Should the company lose such executives, it could impact the company's management and operational performance.
The Company has restructured its management to decentralize operational authority and decision-making, and to delegate scopes of duties and responsibilities to executives in various departments according to their knowledge, capabilities, and experience, as well as establishing a Succession Plan policy and defining the Limits of Authority (LOA) regulations to mitigate the risk of over-reliance on any single executive.
can control the majority vote of the shareholders' meeting, whether it pertains to the appointment of directors, the amendment of the company's articles of association, or the request for approval on other matters requiring a majority vote of the shareholders' meeting.
However, the Company's Board of Directors has structured its board to include no less than one-third of the total number of directors as independent directors (4 independent directors out of a total of 9 directors). The Chairman of the Board is an independent director, and three other independent directors serve as audit committee members to oversee the Company's operations and ensure that all Company actions are for the benefit of the Company. Furthermore, the Company has clearly and transparently defined the scope of operations, duties, responsibilities, and the delegation of authority to directors and executives. Measures have also been established for related party transactions involving directors, major shareholders, controlling persons, and individuals with conflicts of interest. Such individuals shall not have the right to vote on the approval of those transactions, thereby ensuring that the Company's business operations are transparent and serve the best interests of the Company.
The escalating pandemic risk situation is expected to impact the economic and social systems, as well as the operations of the group of companies. By 2025, despite the improving trend of the COVID-19 pandemic, the economy has begun to recover as life returns to normal following the declaration of COVID-19 as an endemic disease. This has enabled tourism and related businesses to resume operations. Nevertheless, outbreaks of COVID-19 due to mutated strains continue to emerge periodically.
The Group continues to prioritize and closely monitor the pandemic situation to assess risks and analyze impacts. This includes continuously maintaining preventive measures and reviewing business continuity plans under emergency conditions should a new outbreak occur, as well as preparing to respond to economic stimulus measures from the government and the Ministry of Public Health.
Risks that may arise from climate change, both as direct threats impacting the group's tangible assets (Physical Risk), leading to direct damage to businesses through the supply chain, such as floods causing harm to businesses, patients, and partners, and as indirect risks resulting from the transmission of physical risks due to climate change (Transition Risk), which affects official regulations for long-term environmental problem-solving, especially the transition to a Low-Carbon Economic Society, potentially impacting various business operating costs or the business's image.
The Group recognizes the significance of climate change risks, which could directly and indirectly affect its reputation and financial stability. The Group has commenced integration by incorporating environmental impact management into its operational system. This involves implementing environmentally friendly processes that cover activities directly contributing to energy conservation and the reduction of greenhouse gas emissions. Additionally, it aims to foster awareness among employees regarding the valuable and optimal utilization of resources.
Cyber threats impact both customers and the corporate group, potentially causing multi-level damage to the corporate group. This includes customer data breaches or violations of patient or partner data, which could result in penalties for the corporate group under the Personal Data Protection Act.
The Group has established risk management measures and responses to cyber threats by defining systematic and continuous guidelines for information technology risk management. This includes procuring and developing tools for detection and monitoring, as well as addressing new and complex forms of cyber attacks. Furthermore, it aims to foster an organizational culture that continuously raises awareness of cyber threats at all levels, from the Board of Directors, executives, and employees, to control potential risks to a level acceptable to the Group.
Unlock full benchmarking
Claim this company to see every KPI your sector qualifies for, from 70+ across the market, benchmarked against sector peers.

